With a robust background in venture capital, the fund manager has effectively built a portfolio centered on technology and healthcare investments across North America and Europe. Having led over 30 deals, their strategic approach emphasizes a data-driven, operator-first style that prioritizes scalable innovations. Notable exits include successful exits in software and biotech, showcasing a keen eye for high-potential startups at the early and growth stages. Their expertise in thematic investing further enhances the ability to identify emerging trends within dynamic markets.